ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 173 filers reported holding ASCENDIS PHARMA A/S in Q2 2021. The put-call ratio across all filers is 4.45 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $5,672,363 | -7.4% | 60,576 | -11.7% | 0.00% | 0.0% |
Q2 2023 | $6,124,233 | +5.7% | 68,619 | +27.0% | 0.00% | 0.0% |
Q1 2023 | $5,793,403 | -12.4% | 54,033 | -0.2% | 0.00% | 0.0% |
Q4 2022 | $6,612,000 | +17.5% | 54,136 | -0.6% | 0.00% | 0.0% |
Q3 2022 | $5,625,000 | +20.6% | 54,467 | +8.6% | 0.00% | 0.0% |
Q2 2022 | $4,663,000 | -23.3% | 50,165 | -3.2% | 0.00% | 0.0% |
Q1 2022 | $6,080,000 | -7.0% | 51,809 | +6.7% | 0.00% | 0.0% |
Q4 2021 | $6,535,000 | -19.9% | 48,577 | -5.1% | 0.00% | -33.3% |
Q3 2021 | $8,159,000 | +18.1% | 51,187 | -2.6% | 0.00% | +50.0% |
Q2 2021 | $6,910,000 | +11.6% | 52,531 | +9.4% | 0.00% | 0.0% |
Q1 2021 | $6,191,000 | -47.1% | 48,037 | -31.5% | 0.00% | -50.0% |
Q4 2020 | $11,700,000 | +4.1% | 70,156 | -3.7% | 0.00% | -20.0% |
Q3 2020 | $11,241,000 | +3.0% | 72,830 | -1.3% | 0.01% | 0.0% |
Q2 2020 | $10,909,000 | +31.4% | 73,763 | +0.1% | 0.01% | +25.0% |
Q1 2020 | $8,299,000 | -39.4% | 73,702 | -25.1% | 0.00% | -33.3% |
Q4 2019 | $13,694,000 | +44.8% | 98,433 | +0.2% | 0.01% | +50.0% |
Q3 2019 | $9,458,000 | -22.5% | 98,193 | -7.4% | 0.00% | -20.0% |
Q2 2019 | $12,209,000 | +63.2% | 106,031 | +66.8% | 0.01% | +66.7% |
Q1 2019 | $7,481,000 | – | 63,583 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RA Capital Management | 5,909,742 | $911,991,000 | 16.68% |
Vivo Capital, LLC | 1,797,745 | $277,428,000 | 16.03% |
Sofinnova Investments, Inc. | 1,109,874 | $171,276,000 | 12.70% |
Asymmetry Capital Management, L.P. | 81,442 | $12,568,000 | 8.08% |
Ghost Tree Capital, LLC | 130,000 | $20,062,000 | 5.80% |
Eversept Partners, LP | 161,004 | $24,846,137 | 5.52% |
Eventide Asset Management | 1,709,848 | $263,864,000 | 5.16% |
Avoro Capital Advisors LLC | 1,800,000 | $277,776,000 | 3.95% |
BERYLSON CAPITAL PARTNERS, LLC | 72,700 | $11,219,000 | 3.93% |
Spyglass Capital Management LLC | 547,022 | $84,416,000 | 3.90% |